1. Home
  2. JYNT vs ANIX Comparison

JYNT vs ANIX Comparison

Compare JYNT & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Joint Corp.

JYNT

The Joint Corp.

HOLD

Current Price

$8.87

Market Cap

120.7M

Sector

Miscellaneous

ML Signal

HOLD

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.88

Market Cap

104.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JYNT
ANIX
Founded
2010
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
120.7M
104.0M
IPO Year
2014
2013

Fundamental Metrics

Financial Performance
Metric
JYNT
ANIX
Price
$8.87
$2.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$17.00
$8.67
AVG Volume (30 Days)
28.5K
109.5K
Earning Date
05-07-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
133.93
12.82
EPS
0.19
N/A
Revenue
$117,696,356.00
$210,000.00
Revenue This Year
$12.23
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$47.68
N/A
Revenue Growth
15.49
N/A
52 Week Low
$7.50
$2.44
52 Week High
$13.47
$5.46

Technical Indicators

Market Signals
Indicator
JYNT
ANIX
Relative Strength Index (RSI) 51.96 50.21
Support Level $8.01 $2.74
Resistance Level $9.05 $3.11
Average True Range (ATR) 0.33 0.16
MACD 0.01 0.01
Stochastic Oscillator 39.77 43.74

Price Performance

Historical Comparison
JYNT
ANIX

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

Share on Social Networks: